Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CorMedix Inc. (CRMD)

3.45   -0.17 (-4.7%) 06-26 22:15
Open: 3.63 Pre. Close: 3.62
High: 3.79 Low: 3.3
Volume: 4,726,131 Market Cap: 135(M)
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.79 - 3.81 3.81 - 3.83
Low: 3.26 - 3.28 3.28 - 3.29
Close: 3.42 - 3.45 3.45 - 3.48

Technical analysis

as of: 2022-06-24 4:39:01 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.42     One year: 5.17
Support: Support1: 3.08    Support2: 2.64
Resistance: Resistance1: 3.78    Resistance2: 4.42
Pivot: 3.02
Moving Average: MA(5): 3.21     MA(20): 3.03
MA(100): 4.07     MA(250): 4.77
MACD: MACD(12,26): -0.1     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 85.1     %D(3): 70.5
RSI: RSI(14): 56.9
52-week: High: 7.15  Low: 2.64
Average Vol(K): 3-Month: 413 (K)  10-Days: 683 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CRMD ] has closed below upper band by 7.0%. Bollinger Bands are 16% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
CorMedix (NYSE:CRMD) Shares Down 4.7% - Defense World

Sat, 04 Jun 2022
Brokerages Anticipate CorMedix Inc. (NYSE:CRMD) to Announce -$0.20 Earnings Per Share - Defense World

Tue, 17 May 2022
CorMedix Inc. (NYSEAMERICAN:CRMD) CEO Joseph Todisco Acquires 10000 Shares - Defense World

Fri, 13 May 2022
CorMedix Inc Common Stock (CRMD) Q1 2022 Earnings Call Transcript - The Motley Fool

Mon, 28 Mar 2022
CRMD stock rises on FDA acceptance of marketing application for lead asset (NASDAQ:CRMD) - Seeking Alpha

Thu, 17 Mar 2022
Health Care Sector Update for 03/17/2022: CPRX,CRMD,AMRX,INM - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 38 (M)
% Held by Insiders 3.825e+007 (%)
% Held by Institutions 1.7 (%)
Shares Short 2,420 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -2.938e+007
EPS Est Next Qtl -0.13
EPS Est This Year -0.53
EPS Est Next Year -0.29
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -15
Return on Assets (ttm) 417.5
Return on Equity (ttm) -31.2
Qtrly Rev. Growth 190940
Gross Profit (p.s.) 0.52
Sales Per Share -23.23
EBITDA (p.s.) 18502.2
Qtrly Earnings Growth -0.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -21 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.15
Price to Cash Flow 4.3

Stock Dividends

Dividend 0
Forward Dividend 2.87e+006
Dividend Yield 0%
Dividend Pay Date 2019-03-25
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.